Vitamin K epoxide reductase complex subunit 1 (VKORC1 ) polymorphism influences the anticoagulation response subsequent to vitamin K intake: a pilot study.

作者信息

Sconce E A, Avery P J, Wynne H A, Kamali F

出版信息

J Thromb Haemost. 2008 Jul;6(7):1226-8. doi: 10.1111/j.1538-7836.2008.03003.x. Epub 2008 Jul 1.

DOI:10.1111/j.1538-7836.2008.03003.x

PMID:18466315

Abstract

摘要

相似文献

Vitamin K epoxide reductase complex subunit 1 (VKORC1 ) polymorphism influences the anticoagulation response subsequent to vitamin K intake: a pilot study.

J Thromb Haemost. 2008 Jul;6(7):1226-8. doi: 10.1111/j.1538-7836.2008.03003.x. Epub 2008 Jul 1.

[Vitamin K epoxide reductase: Fresh blood for oral anticoagulant therapies].

Rev Med Interne. 2006 Dec;27(12):979-82. doi: 10.1016/j.revmed.2006.09.004. Epub 2006 Oct 11.

A vitamin K epoxide reductase complex subunit 1 mutation in an Irish patient with warfarin resistance.

Ir J Med Sci. 2008 Jun;177(2):159-61. doi: 10.1007/s11845-008-0126-2. Epub 2008 Feb 12.

A vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with vitamin K antagonist resistance.

J Thromb Haemost. 2005 Jul;3(7):1533-5. doi: 10.1111/j.1538-7836.2005.01449.x.

Warfarin response and vitamin K epoxide reductase complex 1 in African Americans and Caucasians.

Clin Pharmacol Ther. 2007 May;81(5):742-7. doi: 10.1038/sj.clpt.6100144. Epub 2007 Feb 28.

VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapy.

J Biol Chem. 2013 Oct 4;288(40):28733-42. doi: 10.1074/jbc.M113.457119. Epub 2013 Aug 8.

Influence of CYP2C9 and vitamin k oxide reductase complex (VKORC)1 polymorphisms on time to determine the warfarin maintenance dose.

Pharmazie. 2011 Mar;66(3):222-5.

A vitamin K epoxide reductase-oxidase complex gene polymorphism (-1639G>A) and interindividual variability in the dose-effect of vitamin K antagonists.

J Appl Genet. 2009;50(4):399-403. doi: 10.1007/BF03195700.

Warfarin and vitamin K intake in the era of pharmacogenetics.

Br J Clin Pharmacol. 2010 Aug;70(2):164-70. doi: 10.1111/j.1365-2125.2010.03672.x.

The pharmocogenomics of warfarin: closing in on personalized medicine.

Mol Interv. 2006 Aug;6(4):223-7. doi: 10.1124/mi.6.4.8.

引用本文的文献

The investigation of connection between anticoagulant therapy and vitamin K homologues in human determined by LC-MS/MS.

Bioanalysis. 2024;16(17-18):973-984. doi: 10.1080/17576180.2024.2383109. Epub 2024 Aug 14.

Effects of fasting on warfarin sensitivity index in patients undergoing cardiovascular surgery.

Eur J Clin Pharmacol. 2019 Apr;75(4):561-568. doi: 10.1007/s00228-018-2592-4. Epub 2018 Nov 21.

High intra- and inter-individual variability of plasma vitamin K concentrations in patients with atrial fibrillation under warfarin therapy.

Eur J Clin Nutr. 2015 Jun;69(6):703-6. doi: 10.1038/ejcn.2015.41. Epub 2015 Apr 1.

Nutri-pharmacogenomics of warfarin anticoagulation therapy: VKORC1 genotype-dependent influence of dietary vitamin K intake.

J Thromb Thrombolysis. 2014 Jul;38(1):105-14. doi: 10.1007/s11239-013-0978-9.

Influence of VKORC1 gene polymorphisms on the effect of oral vitamin K supplementation in over-anticoagulated patients.

J Thromb Thrombolysis. 2014 Apr;37(3):338-44. doi: 10.1007/s11239-013-0947-3.

Reversal of oral anticoagulation.

Pharmacotherapy. 2013 Nov;33(11):1199-213. doi: 10.1002/phar.1270. Epub 2013 Apr 18.

Diffuse alveolar hemorrhage in coumarin users: a fibrosing interstitial pneumonia trigger?

Lung. 2013 Feb;191(1):53-9. doi: 10.1007/s00408-012-9436-2. Epub 2012 Nov 13.

Development of cocaine-induced interstitial lung damage in two CYP2C and VKORC1 variant allele carriers.

Mol Diagn Ther. 2011 Jun 1;15(3):177-80. doi: 10.1007/BF03256408.

Warfarin and vitamin K intake in the era of pharmacogenetics.

Br J Clin Pharmacol. 2010 Aug;70(2):164-70. doi: 10.1111/j.1365-2125.2010.03672.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验